Arcus Biosciences Inc banner

Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 23.43 USD 5.97% Market Closed
Market Cap: $2.9B

Wall Street
Price Targets

RCUS Price Targets Summary
Arcus Biosciences Inc

Wall Street analysts forecast RCUS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCUS is 32.95 USD with a low forecast of 20.2 USD and a high forecast of 49.35 USD.

Lowest
Price Target
20.2 USD
14% Downside
Average
Price Target
32.95 USD
41% Upside
Highest
Price Target
49.35 USD
111% Upside
Arcus Biosciences Inc Competitors:
Price Targets
SANA
Sana Biotechnology Inc
150% Upside

Revenue
Forecast

91% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
91% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

For the last 8 years the compound annual growth rate for Arcus Biosciences Inc's revenue is 91%. The projected CAGR for the next 3 years is -2%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-45%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-45%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RCUS's stock price target?
Price Target
32.95 USD

According to Wall Street analysts, the average 1-year price target for RCUS is 32.95 USD with a low forecast of 20.2 USD and a high forecast of 49.35 USD.

What is Arcus Biosciences Inc's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Arcus Biosciences Inc's revenue is 91%. The projected CAGR for the next 3 years is -2%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett